The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 4,491 | 72,970 | SH | SOLE | 72,970 | 0 | 0 | ||
ACADIA HEALTHCARE CO INC | COM | 00404A109 | 6,569 | 186,631 | SH | SOLE | 186,631 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 2,284 | 39,912 | SH | SOLE | 39,912 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 4,331 | 358,191 | SH | SOLE | 358,191 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 3,313 | 33,211 | SH | SOLE | 33,211 | 0 | 0 | ||
CENTENE CORP | COM | 15135B101 | 3,600 | 24,862 | SH | SOLE | 24,862 | 0 | 0 | ||
CVS CAREMARK CORP | COM | 126650100 | 2,824 | 35,870 | SH | SOLE | 35,870 | 0 | 0 | ||
DURECT CORPORATION | COM | 266605104 | 757 | 688,446 | SH | SOLE | 688,446 | 0 | 0 | ||
DAVITA HEALTHCARE PARTNERS I | COM | 23918K108 | 5,263 | 73,471 | SH | SOLE | 73,471 | 0 | 0 | ||
ENDOCYTE | COM | 29269A102 | 1,710 | 96,297 | SH | SOLE | 96,297 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | COM | 37890U108 | 3,931 | 103,449 | SH | SOLE | 103,449 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 285 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
HERON THERAPEUTICS | COM | 427746102 | 1,768 | 55,847 | SH | SOLE | 55,847 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 3,414 | 49,420 | SH | SOLE | 49,420 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 7,283 | 360,182 | SH | SOLE | 360,182 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,910 | 37,021 | SH | SOLE | 37,021 | 0 | 0 | ||
JAZZ PHARMACEUTICALS | COM | G50871105 | 3,723 | 22,144 | SH | SOLE | 22,144 | 0 | 0 | ||
KADMON HOLDINGS INC | COM | 48283N106 | 1,078 | 322,625 | SH | SOLE | 322,625 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,844 | 23,133 | SH | SOLE | 23,133 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 2,981 | 124,517 | SH | SOLE | 124,517 | 0 | 0 | ||
NUCANA PLC-ADR | ADR | 67022C106 | 2,176 | 87,321 | SH | SOLE | 87,321 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 1,789 | 31,379 | SH | SOLE | 31,379 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 1,758 | 105,072 | SH | SOLE | 105,072 | 0 | 0 | ||
ORASURE TECHNOLOGIES INC | COM | 68554V108 | 2,773 | 179,496 | SH | SOLE | 179,496 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 1,974 | 13,187 | SH | SOLE | 13,187 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 3,010 | 68,311 | SH | SOLE | 68,311 | 0 | 0 | ||
PORTOLA PHARMACEUTICALS INC | COM | 737010108 | 6,708 | 251,881 | SH | SOLE | 251,881 | 0 | 0 | ||
PTC THERAPEUTICS | COM | 69366J200 | 8,131 | 173,010 | SH | SOLE | 173,010 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 2,343 | 14,508 | SH | SOLE | 14,508 | 0 | 0 | ||
NEURONETICS INC | COM | 64131A105 | 1,452 | 45,292 | SH | SOLE | 45,292 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 4,082 | 15,344 | SH | SOLE | 15,344 | 0 | 0 | ||
UROVANT SCIENCES LTD | COM | G9381B108 | 1,902 | 158,463 | SH | SOLE | 158,463 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 1,249 | 76,885 | SH | SOLE | 76,885 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 2,438 | 12,650 | SH | SOLE | 12,650 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 2,096 | 223,885 | SH | SOLE | 223,885 | 0 | 0 |